- Home
- SCOR vs OVID Comparison
SCOR vs OVID Comparison
Compare SCOR & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- OVID
- Stock Information
- Founded
- SCOR 1999
- OVID 2014
- Country
- SCOR United States
- OVID United States
- Employees
- SCOR N/A
- OVID N/A
- Industry
- SCOR Business Services
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- SCOR Consumer Discretionary
- OVID Health Care
- Exchange
- SCOR Nasdaq
- OVID Nasdaq
- Market Cap
- SCOR 23.9M
- OVID 20.6M
- IPO Year
- SCOR 2007
- OVID 2017
- Fundamental
- Price
- SCOR $6.25
- OVID $0.56
- Analyst Decision
- SCOR Buy
- OVID Strong Buy
- Analyst Count
- SCOR 2
- OVID 4
- Target Price
- SCOR $10.75
- OVID $3.13
- AVG Volume (30 Days)
- SCOR 25.1K
- OVID 2.4M
- Earning Date
- SCOR 08-05-2025
- OVID 08-19-2025
- Dividend Yield
- SCOR N/A
- OVID N/A
- EPS Growth
- SCOR N/A
- OVID N/A
- EPS
- SCOR N/A
- OVID N/A
- Revenue
- SCOR $358,513,000.00
- OVID $548,000.00
- Revenue This Year
- SCOR $3.36
- OVID N/A
- Revenue Next Year
- SCOR $2.72
- OVID $5.32
- P/E Ratio
- SCOR N/A
- OVID N/A
- Revenue Growth
- SCOR N/A
- OVID 15.61
- 52 Week Low
- SCOR $4.39
- OVID $0.24
- 52 Week High
- SCOR $8.99
- OVID $1.47
- Technical
- Relative Strength Index (RSI)
- SCOR 57.43
- OVID 60.35
- Support Level
- SCOR $4.81
- OVID $0.48
- Resistance Level
- SCOR $7.23
- OVID $0.73
- Average True Range (ATR)
- SCOR 0.56
- OVID 0.05
- MACD
- SCOR 0.13
- OVID -0.01
- Stochastic Oscillator
- SCOR 59.50
- OVID 31.16
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.